BICO Group AB (publ) (BICO.ST)
SEK 34.84
(5.07%)
SEK 34.84
(5.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 10.19 Billion SEK | 4.53% |
| 2021 | 9.75 Billion SEK | 491.42% |
| 2020 | 1.64 Billion SEK | 173.47% |
| 2019 | 603.12 Million SEK | 209.32% |
| 2018 | 194.98 Million SEK | 181.7% |
| 2017 | 69.21 Million SEK | 761.53% |
| 2016 | 8.03 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | 8.85 Billion SEK | -2.79% |
| 2023 Q1 | 10.04 Billion SEK | -1.52% |
| 2023 Q2 | 9.11 Billion SEK | -9.25% |
| 2022 Q1 | 9.84 Billion SEK | 0.95% |
| 2022 Q4 | 10.19 Billion SEK | -5.5% |
| 2022 Q3 | 10.79 Billion SEK | 2.78% |
| 2022 Q2 | 10.49 Billion SEK | 6.61% |
| 2022 FY | 10.19 Billion SEK | 4.53% |
| 2021 Q4 | 9.75 Billion SEK | 43.78% |
| 2021 Q1 | 6.04 Billion SEK | 0.0% |
| 2021 FY | 9.75 Billion SEK | 491.42% |
| 2021 Q2 | 6.69 Billion SEK | 10.66% |
| 2021 Q3 | 6.78 Billion SEK | 1.37% |
| 2020 FY | 1.64 Billion SEK | 173.47% |
| 2020 Q3 | 1.64 Billion SEK | 70.1% |
| 2020 Q1 | 991.91 Million SEK | 62.41% |
| 2020 Q2 | 969.62 Million SEK | -2.25% |
| 2019 Q2 | 246 Million SEK | -0.66% |
| 2019 Q1 | 247.63 Million SEK | 18.37% |
| 2019 Q3 | 603.12 Million SEK | 145.16% |
| 2019 FY | 603.12 Million SEK | 209.32% |
| 2019 Q4 | 610.75 Million SEK | 1.27% |
| 2018 Q2 | 100.04 Million SEK | 2.08% |
| 2018 FY | 194.98 Million SEK | 181.7% |
| 2018 Q4 | 209.2 Million SEK | 7.29% |
| 2018 Q3 | 194.98 Million SEK | 94.89% |
| 2018 Q1 | 98 Million SEK | 2.29% |
| 2017 Q2 | 37.67 Million SEK | -4.67% |
| 2017 Q4 | 95.81 Million SEK | 38.43% |
| 2017 FY | 69.21 Million SEK | 761.53% |
| 2017 Q1 | 39.52 Million SEK | -1.77% |
| 2017 Q3 | 69.21 Million SEK | 83.72% |
| 2016 FY | 8.03 Million SEK | 0.0% |
| 2016 Q4 | 40.23 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -16115.253% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | -210.178% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | -210.178% |
| Arcoma AB | 81.96 Million SEK | -12340.887% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | -1393.21% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | -1250.391% |
| CellaVision AB (publ) | 928.71 Million SEK | -997.951% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -17564.443% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -46343.079% |
| C-Rad AB (publ) | 404 Million SEK | -2423.96% |
| Duearity AB (publ) | 15.14 Million SEK | -67232.277% |
| Dignitana AB (publ) | 44.83 Million SEK | -22644.976% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -9676.414% |
| Getinge AB (publ) | 55.09 Billion SEK | 81.494% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -9834.695% |
| Iconovo AB (publ) | 128.07 Million SEK | -7861.281% |
| Integrum AB (publ) | 164.85 Million SEK | -6085.159% |
| Luxbright AB (publ) | 40.68 Million SEK | -24961.778% |
| Mentice AB (publ) | 322.52 Million SEK | -3061.544% |
| OssDsign AB (publ) | 356.38 Million SEK | -2761.143% |
| Paxman AB (publ) | 167.12 Million SEK | -6001.301% |
| Promimic AB (publ) | 92.87 Million SEK | -10879.058% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -26014.839% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -15749.784% |
| ScandiDos AB (publ) | 81.47 Million SEK | -12415.557% |
| Sectra AB (publ) | 3.21 Billion SEK | -217.565% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | -905.545% |
| Senzime AB (publ) | 433.54 Million SEK | -2251.975% |
| SpectraCure AB (publ) | 144.83 Million SEK | -6940.336% |
| Stille AB | 804.89 Million SEK | -1166.85% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 37.79% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | -364.417% |